Cargando…

Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis

Strongyloides stercoralis is a widely distributed parasite that infects 30 to 100 million people worldwide. In the United States strongyloidiasis is recognized as an important infection in immigrants and refugees. Public health and commercial reference laboratories need a simple and reliable method...

Descripción completa

Detalles Bibliográficos
Autores principales: Rascoe, Lisa N., Price, Courtney, Shin, Sun Hee, McAuliffe, Isabel, Priest, Jeffrey W., Handali, Sukwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393093/
https://www.ncbi.nlm.nih.gov/pubmed/25860665
http://dx.doi.org/10.1371/journal.pntd.0003694
_version_ 1782366099153616896
author Rascoe, Lisa N.
Price, Courtney
Shin, Sun Hee
McAuliffe, Isabel
Priest, Jeffrey W.
Handali, Sukwan
author_facet Rascoe, Lisa N.
Price, Courtney
Shin, Sun Hee
McAuliffe, Isabel
Priest, Jeffrey W.
Handali, Sukwan
author_sort Rascoe, Lisa N.
collection PubMed
description Strongyloides stercoralis is a widely distributed parasite that infects 30 to 100 million people worldwide. In the United States strongyloidiasis is recognized as an important infection in immigrants and refugees. Public health and commercial reference laboratories need a simple and reliable method for diagnosis of strongyloidiasis to identify and treat cases and to prevent transmission. The recognized laboratory test of choice for diagnosis of strongyloidiasis is detection of disease specific antibodies, most commonly using a crude parasite extract for detection of IgG antibodies. Recently, a luciferase tagged recombinant protein of S. stercoralis, Ss-NIE-1, has been used in a luciferase immunoprecipitation system (LIPS) to detect IgG and IgG(4) specific antibodies. To promote wider adoption of immunoassays for strongyloidiasis, we used the Ss-NIE-1 recombinant antigen without the luciferase tag and developed ELISA and fluorescent bead (Luminex) assays to detect S. stercoralis specific IgG(4). We evaluated the assays using well-characterized sera from persons with or without presumed strongyloidiasis. The sensitivity and specificity of Ss-NIE-1 IgG(4) ELISA were 95% and 93%, respectively. For the IgG(4) Luminex assay, the sensitivity and specificity were 93% and 95%, respectively. Specific IgG4 antibody decreased after treatment in a manner that was similar to the decrease of specific IgG measured in the crude IgG ELISA. The sensitivities of the Ss-NIE-1 IgG(4) ELISA and Luminex assays were comparable to the crude IgG ELISA but with improved specificities. However, the Ss-NIE-1 based assays are not dependent on native parasite materials and can be performed using widely available laboratory equipment. In conclusion, these newly developed Ss-NIE-1 based immunoassays can be readily adopted by public health and commercial reference laboratories for routine screening and clinical diagnosis of S. stercoralis infection in refugees and immigrants in the United States.
format Online
Article
Text
id pubmed-4393093
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43930932015-04-21 Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis Rascoe, Lisa N. Price, Courtney Shin, Sun Hee McAuliffe, Isabel Priest, Jeffrey W. Handali, Sukwan PLoS Negl Trop Dis Research Article Strongyloides stercoralis is a widely distributed parasite that infects 30 to 100 million people worldwide. In the United States strongyloidiasis is recognized as an important infection in immigrants and refugees. Public health and commercial reference laboratories need a simple and reliable method for diagnosis of strongyloidiasis to identify and treat cases and to prevent transmission. The recognized laboratory test of choice for diagnosis of strongyloidiasis is detection of disease specific antibodies, most commonly using a crude parasite extract for detection of IgG antibodies. Recently, a luciferase tagged recombinant protein of S. stercoralis, Ss-NIE-1, has been used in a luciferase immunoprecipitation system (LIPS) to detect IgG and IgG(4) specific antibodies. To promote wider adoption of immunoassays for strongyloidiasis, we used the Ss-NIE-1 recombinant antigen without the luciferase tag and developed ELISA and fluorescent bead (Luminex) assays to detect S. stercoralis specific IgG(4). We evaluated the assays using well-characterized sera from persons with or without presumed strongyloidiasis. The sensitivity and specificity of Ss-NIE-1 IgG(4) ELISA were 95% and 93%, respectively. For the IgG(4) Luminex assay, the sensitivity and specificity were 93% and 95%, respectively. Specific IgG4 antibody decreased after treatment in a manner that was similar to the decrease of specific IgG measured in the crude IgG ELISA. The sensitivities of the Ss-NIE-1 IgG(4) ELISA and Luminex assays were comparable to the crude IgG ELISA but with improved specificities. However, the Ss-NIE-1 based assays are not dependent on native parasite materials and can be performed using widely available laboratory equipment. In conclusion, these newly developed Ss-NIE-1 based immunoassays can be readily adopted by public health and commercial reference laboratories for routine screening and clinical diagnosis of S. stercoralis infection in refugees and immigrants in the United States. Public Library of Science 2015-04-10 /pmc/articles/PMC4393093/ /pubmed/25860665 http://dx.doi.org/10.1371/journal.pntd.0003694 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Rascoe, Lisa N.
Price, Courtney
Shin, Sun Hee
McAuliffe, Isabel
Priest, Jeffrey W.
Handali, Sukwan
Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis
title Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis
title_full Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis
title_fullStr Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis
title_full_unstemmed Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis
title_short Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis
title_sort development of ss-nie-1 recombinant antigen based assays for immunodiagnosis of strongyloidiasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393093/
https://www.ncbi.nlm.nih.gov/pubmed/25860665
http://dx.doi.org/10.1371/journal.pntd.0003694
work_keys_str_mv AT rascoelisan developmentofssnie1recombinantantigenbasedassaysforimmunodiagnosisofstrongyloidiasis
AT pricecourtney developmentofssnie1recombinantantigenbasedassaysforimmunodiagnosisofstrongyloidiasis
AT shinsunhee developmentofssnie1recombinantantigenbasedassaysforimmunodiagnosisofstrongyloidiasis
AT mcauliffeisabel developmentofssnie1recombinantantigenbasedassaysforimmunodiagnosisofstrongyloidiasis
AT priestjeffreyw developmentofssnie1recombinantantigenbasedassaysforimmunodiagnosisofstrongyloidiasis
AT handalisukwan developmentofssnie1recombinantantigenbasedassaysforimmunodiagnosisofstrongyloidiasis